Chronic Pain: The Other Factors

This workshop will examine the wider issues in chronic pain including past trauma, the socio-economic aspects of disability, and the role of the pharmaceutical industry. The workshop will explore clinical strategies for addressing these, including psychosocial treatments and motivational interviewing. New developments in the use of buprenorphine for the treatment of chronic pain also will be presented. (Planners: Karen Miotto, MD, Chair; P. Joseph Frawley, MD; Anna Lembke, MD; Nicola Longmuir, MD)

| John J. Coleman, MA, MS, PhD, President, Prescription Drug Research Center, Fairfax, VA Medical Center | Anna Lembke, MD, Program Director, Stanford Addiction Medicine Program (SAMP); Assistant Professor, Department of Psychiatry and Behavioral Sciences, Stanford University | P. Joseph Frawley, MD, Private practice in the treatment of addiction and management of chronic pain, Santa Barbara, CA